The European Biopharmaceutical Enterprises (EBE) has appointed a new president, Ahmed Bouzidi. Dr Bouzidi has been a board member of EBE since its inception until 2003, re-joining the EBE Board in 2012.
Ahmed Bouzidi is the founder and Chief Executive Officer of Vaxeal which is one of the projects being funded by Keyholder. It is great news for Vaxeal and Keyholder that Dr. Bouzidi has been appointed to this position.
On his appointment as President, Ahmed Bouzidi said “I would like to thank Eduardo Bravo and Andrea Chiesi, the previous president and vice-president, for their great job over the past two years. I am honoured to take on this role at such an important time for EBE. I very much look forward to working with François and our colleagues to tackle the many exciting opportunities and challenges being presented by the biopharmaceutical industry in Europe”